David Colligan

ORCID: 0000-0001-7637-5325
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mesenchymal stem cell research
  • Blood donation and transfusion practices
  • Organ Donation and Transplantation
  • Pancreatic function and diabetes
  • Digital Platforms and Economics
  • Artificial Intelligence in Healthcare and Education
  • Business Process Modeling and Analysis
  • Cloud Data Security Solutions
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • Outsourcing and Supply Chain Management
  • Blood transfusion and management
  • Diverse Global Research Studies
  • Service-Oriented Architecture and Web Services
  • Energy Harvesting in Wireless Networks
  • FinTech, Crowdfunding, Digital Finance
  • Biomedical Ethics and Regulation

Scottish National Blood Transfusion Service
2013-2020

Victoria University of Wellington
2003

University of Sheffield
2000

Abstract. This paper focuses on Cap Gemini’s electronic commerce system, TransLease. TransLease is an interorganizational information system (IOS), which facilitates between motor vehicle leasing and repair companies. During our investigation, the was used by approximately 1000 agents working for seven of UK’s leading contract hire originally developed AT&T acquired Gemini in July 1998. At time acquisition, seen as being high strategic value, although it also underperforming. reports...

10.1046/j.1365-2575.2000.00078.x article EN Information Systems Journal 2000-01-01

Islet transplantation is an efficacious therapy for type 1 diabetes; however, islets from multiple donor pancreata are required, and a gradual attrition in transplant function seen. Here, we manufactured human umbilical cord perivascular mesenchymal stromal cells (HUCPVCs) to Good Manufacturing Practice (GMP) standards. HUCPVCs showed stable phenotype while undergoing rapid ex vivo expansion at passage 2 (p2) 4 (p4) produced proregenerative factors, strongly suppressing T cell responses the...

10.1126/scitranslmed.aan5907 article EN Science Translational Medicine 2020-01-15

Mesenchymal stromal cells (MSCs) isolated from various tissues are under investigation as cellular therapeutics in a wide range of diseases. It is appreciated that the basic biological functions MSCs vary depending on tissue source. However, in-depth comparative analyses between different sources Good Manufacturing Practice (GMP) conditions lacking. Human clinical-grade low-purity islet (LPI) fractions generated byproduct isolation for transplantation. MSC isolates were derived LPI with aim...

10.1016/j.jcyt.2020.07.010 article EN cc-by-nc-nd Cytotherapy 2020-08-20
Coming Soon ...